Nephros
NEPH
21 hedge funds and large institutions have $35.7M invested in Nephros in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 3 closing their positions.
24% more capital invested
Capital invested by funds: $28.9M → $35.7M (+$6.82M)
0% more funds holding
Funds holding: 21 → 21 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
1.05% less ownership
Funds ownership: 48.6% → 47.55% (-1.1%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Overbrook Management Corp
New York
|
+$1.03M |
| 2 |
Renaissance Technologies
New York
|
+$142K |
| 3 |
BlackRock
New York
|
+$133K |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$15.8K |
| 5 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
+$8.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
-$890K |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
-$839K |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$40.4K |
| 4 |
Millennium Management
New York
|
-$8.64K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.73K |
NEPH Hedge Fund Activity: Q2 2020 in Review
21 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q2 2020, worth a combined $35.7M — up 24% from $28.9M a quarter earlier.
Fund positioning in NEPH was balanced in Q2 2020: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 7 trimmed.
The largest buyer was Overbrook Management Corp, opening a new position worth an estimated $1.03M. The largest seller was Cowen Prime Advisors, cutting an estimated $890K.
- 21 institutional investors held Nephros (NEPH) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $35.7M of Nephros stock for Q2 2020, up 24% quarter-over-quarter.
- 3 funds opened new Nephros positions in Q2 2020 and 3 closed out, a net change of 0 holders.
- The largest Nephros buyer in Q2 2020 was Overbrook Management Corp, an estimated $1.03M added.
- The largest Nephros seller in Q2 2020 was Cowen Prime Advisors, an estimated $890K sold.
Based on aggregated 13F filings for Q2 2020.